Literature DB >> 21769514

[Pneumonia in the elderly: results of quality improvement program for a geriatric department in Lower Saxony 2006-2009].

M Gogol1, D Schmidt, A Dettmer-Flügge, B Vaske.   

Abstract

BACKGROUND: Is the time to diagnosis and to start antibiotic therapy a major factor contributing to the outcome in geriatric patients?
METHODS: In 2006, a program for documentation and improvement for diagnostic and therapeutic procedures in patients with community-acquired pneumonia was introduced in German hospitals. The analyses were performed centrally by an independent board.
SETTING: Tertiary geriatric department with 70 beds for acute care and rehabilitation in a hospital, also including a department of neurology and neurological rehabilitation.
RESULTS: In Lower Saxony (LS), 81,853 patients were treated between 2006-2009 in our geriatric department (GD). In LS, 55.3% of the population was male, while 45.2% of the patients in the GD were male (p=0.063). Throughout an age of 79 years, the distribution was equal; however in the age groups 80-89 years (LS vs GD: 32.3 vs 47.6%) and >90 years (LS vs GD: 10.2 vs 15.5%, p<0.001) there were a higher proportion of male patients in the GD. The proportion of male nursing home patients was 46.8% vs 24.3%, hospital or rehabilitation unit 6.2% vs 40.5%, and status of confinement to bed was 47% vs 35.1% (LS vs GD, p<0.001). Delirium caused by pneumonia occurred in 24.4% vs 9.3% and a status of chronic delirium (dementia) was assessed by 75.6% vs. 90.7% of all cases (LS vs GD, p=0.021). The distribution about the risk classes 1/2/3 of the CRB-65 score was 14.9/76.9/8.2% in LS and 3.6/89.3/7.1% in the GD (p=0.011). The time to starting antibiotics (no therapy, <4, 4-8, and >8 h) was 2.2/83.0/7.6/7.2% in LS and 15.4/47.4/10.3/26.9% in GD patients (p<0.001). Overall mortality rates did not differ significantly (LS 14.6% vs GD 11.9%, p=0.53).
CONCLUSIONS: Patients in the GD were older and more functionally dependent. The distribution of the risk index CRB-65 shows that these patients were at higher risk, were more often cognitively impaired (not caused by pneumonia), and time to starting antibiotics was longer. However, none of these differences had an influence on total mortality. The results are limited by the number of patients, potential differences of the treatment groups, and the quality of data in general as a result of a quality improvement program.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21769514     DOI: 10.1007/s00391-011-0217-y

Source DB:  PubMed          Journal:  Z Gerontol Geriatr        ISSN: 0948-6704            Impact factor:   1.281


  28 in total

1.  BTS Guidelines for the Management of Community Acquired Pneumonia in Adults.

Authors: 
Journal:  Thorax       Date:  2001-12       Impact factor: 9.139

2.  Processes of care, illness severity, and outcomes in the management of community-acquired pneumonia at academic hospitals.

Authors:  J Dedier; D E Singer; Y Chang; M Moore; S J Atlas
Journal:  Arch Intern Med       Date:  2001-09-24

3.  Community-acquired pneumonia guidelines: much guidance, but not much evidence.

Authors:  M Woodhead
Journal:  Eur Respir J       Date:  2002-07       Impact factor: 16.671

4.  Optimizing therapy for community-acquired pneumonia with the goal of rapid resolution of illness.

Authors:  Thomas M File; James S Tan
Journal:  Clin Infect Dis       Date:  2005-11-10       Impact factor: 9.079

5.  JCAHO tweaks emergency departments' pneumonia treatment standards.

Authors:  Mike Mitka
Journal:  JAMA       Date:  2007-04-25       Impact factor: 56.272

Review 6.  Evidence-based emergency medicine/critically appraised topic. Evidence behind the 4-hour rule for initiation of antibiotic therapy in community-acquired pneumonia.

Authors:  Kenneth T Yu; Peter C Wyer
Journal:  Ann Emerg Med       Date:  2008-02-13       Impact factor: 5.721

Review 7.  Timing of antibiotics for acute, severe infections.

Authors:  Jesse M Pines
Journal:  Emerg Med Clin North Am       Date:  2008-05       Impact factor: 2.264

8.  Comparison between pathogen directed antibiotic treatment and empirical broad spectrum antibiotic treatment in patients with community acquired pneumonia: a prospective randomised study.

Authors:  M M van der Eerden; F Vlaspolder; C S de Graaff; T Groot; W Bronsveld; H M Jansen; W G Boersma
Journal:  Thorax       Date:  2005-08       Impact factor: 9.139

9.  Antibiotic timing and diagnostic uncertainty in Medicare patients with pneumonia: is it reasonable to expect all patients to receive antibiotics within 4 hours?

Authors:  Mark L Metersky; Thomas A Sweeney; Martin B Getzow; Farhan Siddiqui; Wato Nsa; Dale W Bratzler
Journal:  Chest       Date:  2006-07       Impact factor: 9.410

10.  Early administration of antibiotics does not shorten time to clinical stability in patients with moderate-to-severe community-acquired pneumonia.

Authors:  Steven H Silber; Christopher Garrett; Rakesh Singh; Angela Sweeney; Carl Rosenberg; Diana Parachiv; Tobi Okafo
Journal:  Chest       Date:  2003-11       Impact factor: 9.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.